Authors
Loading...
This analysis reveals naringenin's binding properties to breast cancer proteins, suggesting promising anticancer effects.
Viji et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: